Page last updated: 2024-08-26

nsc-87877 and sb 203580

nsc-87877 has been researched along with sb 203580 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbieri, E; Chen, Z; Cheng, J; Fan, Y; Jin, J; Kim, ES; Ma, IT; Patel, RH; Rojas, Y; Shang, X; Shi, Y; Shohet, JM; Vasudevan, SA; Yang, J; Yu, Y; Zhao, Y1

Other Studies

1 other study(ies) available for nsc-87877 and sb 203580

ArticleYear
NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis.
    Cell death & disease, 2015, Aug-06, Volume: 6

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Caspase 3; Cell Line, Tumor; Dual-Specificity Phosphatases; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Kidney; Mice; Mice, Nude; Mitogen-Activated Protein Kinase Phosphatases; Molecular Chaperones; Neuroblastoma; p38 Mitogen-Activated Protein Kinases; Poly(ADP-ribose) Polymerases; Protein Serine-Threonine Kinases; Pyridines; Quinolines; RNA, Small Interfering; Signal Transduction; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2015